|
![]() |
|||
|
||||
OverviewIn Inflammation in the Pathogenesis of Chronic Diseases: The COX-2 Controversy, a worldwide panel of leading experts discusses the role of inflammation in the pathogenesis of major chronic diseases and the current controversy regarding risk versus benefit of selective cyclooxygenase-2 (COX-2) inhibitors. This volume is intended for scientists in medicine, epidemiology, pharmacology, molecular biology, and related fields. The authors provide exciting and enlightening perspectives on COX-2 and related molecular targets in the future of medicine, including historical perspectives on the discovery and development of aspirin, ibuprofen, and compounds that selectively inhibit COX-2, and the potential for development of new compounds with better efficacy and safety in the 21st century. Specfic chapters illuminate the role of inflammatory mechanisms in the pathogenesis of arthritis, cardiovascular disease, cancer, neurodegenerative disease, diabetes mellitus, obesity, and other life-threatening and debilitating conditions. Experts in cardiovascular medicine explore the COX-2 controversy regarding adverse effects of some (not all) selective COX-2 inhibitors on the cardiovasculature. Recent findings suggest that cardiovascular risk associated with some COX-2 inhibitors may not be due to a class effect, but rather depends upon the molecular structure of specific compounds. Important findings are documented in cancer research showing that selective COX-2 inhibitors have powerful antineoplastic effects against major forms of cancer. A special section explores the current evidence supporting the role of COX-2 and inflammation in the development of Alzheimer's disease and other neurodegenerative conditions and the potential benefit of compounds that modulate COX-2 and other inflammatory cytokines. The final section addresses nutritional modulation of inflammation and the chemopreventive value of anti-inflammatory nutraceutical agents. Full Product DetailsAuthor: Randall E HarrisPublisher: Springer Imprint: Springer Dimensions: Width: 23.40cm , Height: 1.80cm , Length: 15.60cm Weight: 0.485kg ISBN: 9789048112043ISBN 10: 9048112044 Pages: 348 Publication Date: 25 August 2008 Audience: General/trade , General Format: Undefined Publisher's Status: Unknown Availability: Out of stock ![]() Table of ContentsReviewsFrom the reviews: This is an up-to-date review of the current understanding of inflammation, the mechanisms by which it affects disease, and the role of anti-inflammatory medications pertaining to COX-2 and its inhibition. Physicians and researchers with a particular interest in the current research and understanding of inflammation and COX-2 inhibition are the intended readers. It is detailed, but written with great clarity and exhaustive references. It will be a great addition to any medical library. (Vladimir N. Despotovic, Doody s Review Service, February, 2010) Author InformationTab Content 6Author Website:Countries AvailableAll regions |